Streptococcus pyogenes infects human endometrium by limiting its immune response by Weckel, Antonin et al.
HAL Id: hal-02349612
https://hal.archives-ouvertes.fr/hal-02349612
Submitted on 5 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Streptococcus pyogenes infects human endometrium by
limiting its immune response
Antonin Weckel, Thomas Guilbert, Clara Lambert, Céline Plainvert, François
Goffinet, Claire Poyart, Céline Méhats, Agnès Fouet
To cite this version:
Antonin Weckel, Thomas Guilbert, Clara Lambert, Céline Plainvert, François Goffinet, et al.. Strep-
tococcus pyogenes infects human endometrium by limiting its immune response. 2019. ￿hal-02349612￿
 1 
Streptococcus pyogenes infects human endometrium by limiting its 
immune response 
 
Antonin Weckel1,2,3,4, Thomas Guilbert1,2,3, Clara Lambert1,2,3,4, Céline 
Plainvert1,2,3,4,5,6, François Goffinet4,7,8, Claire Poyart1,2,3,4,5,6, Céline 
Méhats1,2,3,4,*, Agnès Fouet1,2,3,4,5,* 
 
1INSERM U1016, Institut Cochin, 2CNRS UMR 8104, 3Université Paris Descartes (UMR-
S1016) 75014 Paris, France, 4Département Hospitalo-Universitaire Risk & Pregnancy, Port 
Royal Maternity, 5Centre National de Référence des Streptocoques, 6Hôpitaux Universitaires 
Paris Centre, Cochin, Assistance Publique Hôpitaux de Paris, 7Faculté de Médecine, 
Université Paris Descartes, 8Service de Gynécologie Obstétrique I, Maternité Port Royal, 
Assistance Publique-Hôpitaux de Paris. 
*These authors contributed equally.  
 
AW current address: University of California, San Francisco, 513 Parnassus Ave, San 
Francisco, CA 94143, United States of America 
Correspondance: Agnes Fouet 22 rue Méchain 75014 Paris, France + 33 1 40 51 64 50 
agnes.fouet@inserm.fr 
 
The authors have declared that no conflict of interest exists. 
  
 2 
Abstract  
Group A Streptococcus (GAS), a Gram-positive human-specific pathogen yields 517,000 
deaths annually worldwide, including 163,000 due to invasive infections and among them 
puerperal fever. GAS is their most feared etiologic agent. Puerperal fever still accounts for 
more than 75,000 maternal deaths annually and before the introduction of efficient 
prophylactic measures 10% childbirths were followed by the mother’s death. Yet little is 
known regarding GAS invasive infection establishment or GAS efficiency in causing 
postpartum infection. To characterize its early steps, we set up coordinated analyses of ex vivo 
infection of the human decidua, the puerperal fever portal of entry. We analyzed GAS 
behavior and the immune response triggered. We demonstrate that GAS (i) benefits from 
tissue secreted products to multiply; (ii) invades the tissue and leads to the death of half the 
cells within two hours via SpeB protease and Streptolysin O activities, respectively; (iii) 
impairs the tissue immune response. Immune impairment occurs both at the RNA level, with 
the induction of only a restricted immediate innate immune response, and at the protein level, 
in a SLO- and SpeB-dependent manner. Our study indicates that GAS efficient decidua 
invasion and immune response restraint favor its propensity to develop rapid invasive 
infections in a gynecological-obstetrical context.  
 3 
Introduction 
Puerperal fever currently accounts for > 75,000 maternal deaths annually. Streptococcus 
pyogenes, also known as Group A Streptococcus (GAS), a Gram-positive human-specific 
pathogen, is its most feared etiologic agent (1). Between 2010-2016, GAS was responsible for 
56 and 109 cases/100 000 persons per year of postpartum infections in the USA and the UK, 
respectively (2,3). In France, 65% and 55% of GAS invasive infections occurred in the 
gyneco-obstetrical sphere for women between 18- and 40-years of age, in 2017 and 2018, 
respectively. In addition to puerperal fever, GAS causes a wide range of infections, from non-
invasive infections, such as pharyngitis and impetigo, to invasive infections, such as 
necrotizing fasciitis, bacteremia and streptococcic toxic shock syndrome, responsible 
altogether for 163,000 deaths annually (4). Finally, post-streptococcal sequelae, such as 
glomerulonephritis and rheumatic arthritis, are auto-immune diseases leading to 354,000 
deaths annually. Virulence factors contributing to invasive diseases, including the 
extracellular cysteine protease SpeB and cytotoxin Streptolysin O (SLO), have been described 
in vitro and confirmed in vivo in animal models of infection (5–7). SpeB cleaves many host 
molecules, degrading, for example, fibronectin, fibrinogen, plasminogen and vitronectin, or 
activating, for example, matrix metalloproteases and IL-1b (for review (8)). SLO, in addition 
to being a pore forming toxin, facilitates the entry of the NAD glycohydrolase into eukaryotic 
cells and together these toxins contribute to cell lysis and to GAS pathogenesis (9,10). 
In contrast to commensals or other pathogens, GAS does not colonize the vagina in the 
steady state (11). Yet before the introduction of efficient hygienic prophylactic measures, up 
to 10% post-partum women died of puerperal fever in lying-in hospitals. Furthermore, half of 
the cases of GAS-related puerperal fever occur within the first two days postpartum, with 
very rapid progression to severe sepsis (12). Hence, we hypothesized that GAS efficiently and 
promptly infects the decidua. The decidua is the mucosal uterine-lining during pregnancy and 
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after childbirth. This tissue is made up of endometrial decidualized stromal cells, not 
epithelial cells, and 40% of resident leucocytes (13). Our team already showed that GAS 
readily adheres to primary human decidual stromal cells (14). However, to our knowledge, the 
early steps of human decidua infection by GAS or even, on a broader outlook, of GAS tissue 
invasion have never been characterized ex vivo on a human tissue.  
The current model describing the invasive infections early steps, supported by studies 
on an infection model of 3D organotypic human skin, suggests adhesion to host tissue, 
growth, invasion of the tissue within 24 h pi (15). These are followed by resistance to immune 
responses, tissue destruction and systemic GAS infection (16). The observation of necrotizing 
fasciitis biopsy support the in vivo relevance of these results (15). However, questions remain 
regarding the events occurring during the first hours of infection of the tissues, particularly 
whenever GAS is in contact with stromal tissues such as the decidua. We aimed at 
characterizing these events, at identifying causes of the apparent efficiency of GAS to rapidly 
elicit puerperal fever and at unraveling mechanisms involved. 
To that effect, we resorted to infect ex vivo human decidua and to characterize 
different aspects of the infection via multiple approaches. Since the immunological status of 
the decidua at the time of birth is particular (17), we infected ex vivo the upper portion of the 
decidua that is sloughed off with the placenta (18). The experiments were carried out on a 
timescale ranging from 15 min to several hours and we analyzed the different steps of the 
process relevant to invasive infections. Also, GAS is genetically diverse, up to 15% of the 
genome being composed of genetic mobile elements that furthermore carry virulence factors 
(19). Strain genotyping relies on the sequence of the 5’-end of the emm gene and more than 
200 emm-types exist (20). emm28 strains are associated with obstetrical and gynecological 
infections and the emm28-type is among the three most prevalent emm-types involved in 
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invasive infections (21–23). We therefore infected the decidua with a wild-type (WT) emm28 
clinical strain isolated from a puerperal fever and its GFP and mutant derivatives (24).  
We show that GAS benefits from tissue secreted product to multiply at the decidual 
surface, that it invades the tissue in the first 8 hours of infection and that it kills half of the 
cells within two hours. The role of two major virulence factors, SpeB and SLO, on these 
phenotypes is documented; SpeB is involved in the tissue invasion and SLO in the 
cytotoxicity. The tissue immune response is also characterized at transcriptional and protein 
accumulation levels, with SpeB and SLO modifying cytokine accumulation.  
 6 
Results 
GAS grows on human decidua during early steps of infection. Human decidual explants were 
infected with a wild-type isolate derivative expressing GFP (GFP-WT) (Figure 1). We used 
two complementary approaches to follow tissue colonization and invasion: either the tissue 
was infected under static conditions (sc) and fixed at different time points or, for live 
microscopy, under flow conditions (fc). GAS efficiently adheres to the tissue surface that 
contains a fibronectin layer covering the decidual cells. These cells are embedded in an 
extracellular matrix containing type IV collagen (Figure 1A). Furthermore, at 24 h pi sc, GAS 
formed microcolonies of up to 16 µm thick (Figure 1B) indicating the successful tissue 
surface colonization by GAS. We quantified GAS multiplication at the tissue surface during 
the first hours pi fc. In contact with 5 out of 6 tissues (Table S1), GAS multiplies until it 
covers the whole tissue surface (Figure 1C, 1D, Supp video 1). We measured the growth 
parameters of initially scattered bacteria. GAS grows exponentially at the tissue surface with 
the colonized surface doubling every 82 minutes (Figure 1E, 1F, Supp video 2). We also 
quantified the increase in bacterial thickness (Figure 1G, 1H). Its mean value doubled in 4 
hours reaching a mean value of 4.2 µm (Figure 1H). For any given subject, the increase in 
thickness was locally heterogeneous with, after 6 h, hot-spots of more than 10 µm thick 
(Figure 1G). Yet, the overall thickness increase was alike on all subjects considered (Figure 
1G, 1H). Hence, GAS grows in all three dimensions, with an apparent doubling time slightly 
below 80 min, accounting for its robust capacity to infect the human decidua. 
To analyze if diffusible host factors promoted GAS growth, we compared GAS 
growth in the infection medium, RPMI, and in tissue-conditioned supernatants (Figure 1I). 
Whereas GAS does not multiply in RPMI, it multiplied in conditioned supernatants from 5 
subjects and died in the other three (Table S1, Figure 1I). This suggests that, and non-
exclusively, some tissues secreted nutrients and some bactericidal molecules. The 
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antimicrobial peptides (AMP) human defensins (hBD) 1 and 2 and LL-37 were previously 
shown to be present in decidua during pregnancy (25). To define whether their amount could 
explain GAS growth limitation, we assayed the concentration of these AMPs in conditioned 
supernatants (Figure 1J). The hBD1 and hBD2 amounts were similar for all uninfected 
supernatants and that of LL-37 not significantly different, thus AMPs concentration do not 
seem predictive of growth possibility in the supernatants (Figure 1I). 
GAS invades the human decidua ex vivo. We then characterized GAS penetration of the 
decidua. While GAS is non-motile, bacteria were readily 4-5 micrometers below the tissue 
surface at 16 h pi sc (Figure 2A, S1A). To analyze the propensity of such events, we 
quantified invasion events through automated image analysis. As soon as 4 h pi sc, there are 
an average of 600 invasion events per mm² (Figure 2B); this corresponds to approximately 
two invading chains per 1000 surface chains. Furthermore, there are three times more intra-
tissular bacteria at 8 h than at 4 h pi (Figure 2C). We hypothesized that GAS invasion is partly 
due to tissue degradation, especially fibronectin degradation, and that SpeB, GAS major 
protease which degrades fibronectin (26), is involved in tissue penetration. To test this 
hypothesis, we infected decidua with either the WT or a DSpeB strain. At 4 h pi the DSpeB 
strain invaded the tissue two-fold less efficiently than the WT strain demonstrating that SpeB 
contributes to tissue invasion (Figure 2C). This suggests a possible involvement of matrix 
protein degradation in tissue invasion. Another potential source of bacterial invasion is 
internalization into host cells. We observed phagocytosis of GAS by immune cells 15 min pi 
fc and bacteria were found inside immune cells 6 µm below the tissue surface up to at least 4 
h pi (Figure 2D, 2E, S1B), indicating that GAS may invade the tissue as intra-cellular 
bacteria. Our results indicate that GAS can rapidly and actively invade the decidua by an 
SpeB-dependent mechanism and may exploit survival in decidual immune cells.  
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GAS induces cell death. GAS is known to induce cytotoxicity (27). We thus analyzed the 
consequences of ex vivo GAS infection of the human decidua on the physical state of cells. As 
soon as 4 h pi sc, we observed, as indicated by CD45 membrane protein visualization and 
DAPI staining, blebbing and dying immune cells (Figure 3A, Supp video 3) and at 16 h pi sc, 
by TUNEL assay, nuclei with altered morphology and DNA damages (Figure 3B). All cell-
types, immune (CD45+) and non-immune (CD45-), were damaged (TUNEL+) (Figure 3C). 
We quantified the cytotoxicity induced by the infection at 2 and 8 h pi (Figure 3D, 3E). 
Twenty-seven % and 57% of cells were TUNEL positive at 2 h and 8 h pi, respectively, 
compared to 7% and 11% without infection (Figure 3E). To determine if cell death was 
induced by a GAS secreted factor, we measured cytotoxicity when bacteria were physically 
isolated from the tissue via a Transwell® insert (Figure 3E). In these conditions, GAS was 
still able to induce 21% and 37% of cell death at 2 h and 8 h pi, respectively, which 
demonstrates that GAS secreted factors induce cell death. Yet these values are lower than 
when bacteria are in contact with the tissues suggesting that direct contact or proximity is 
involved in the cytotoxicity efficiency. SLO (28,29) being a pore-forming toxin described to 
induce cell death, we tested to which extent this protein was involved in GAS cytotoxicity on 
the whole tissue at 2 and 4 h pi, infecting both primary decidual stromal cells and the decidua 
(Figure 3F, 3G). On primary decidual cells at 4 h pi, the WT and isogenic revertant (BTSLO) 
strains induced 60 % and 54% cytotoxicity, the isogenic SLO deleted mutant strain (ΔSLO) 
only 14%; in the non-infected condition there was only 7% cytotoxicity (Figure 3F). Hence, 
SLO is involved in the GAS cytotoxic effect. Also, on the decidual tissue, at 2 and 4 h pi, the 
ΔSLO strain is twice less cytotoxic than the WT strain (25 and 33% versus 43 and 60 %, 
respectively) (Figure 3G). However, at both time-points, the ΔSLO strain still induced a 
significant cytotoxicity compared to the non-infected control (26 and 33 % versus 1.6 and 1.4 
%, respectively), indicating that GAS produces cytotoxic molecules other than SLO. In 
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conclusion, GAS yields dramatic cell damages within a few hours of infection of the decidua 
and SLO, together with other secreted factors, is involved in the toxicity. 
GAS limits the tissue immune response. The efficient bacterial multiplication 
questioned the host immune response. We first analyzed the expression of 133 unique 
immune genes related to “Inflammatory cytokines and receptors” and “Human innate & 
adaptive response” pathways of four independent subjects (Figure 4). Prior to infection, there 
is, as expected, low to moderate expression of the majority of the genes tested (Figure 4A, 
Table S1) (30). The 10% most highly expressed genes are related to “macrophage” and 
“cytokine-mediated signaling pathway”, reflecting the capacity of the decidua to generate an 
immune response. We next investigated the change in the host immune response at 8 h pi. Ten 
genes among the 133 tested showed a significant overexpression; they all encode cytokines 
and chemokines related to the ontology pathways, “acute inflammatory response” and 
“macrophages” (Figure 4A, Table S2). Among the 10 overexpressed genes, TNF, CXCL1, 
CXCL2, and IL23a are paradigmatic of an immediate early gene primary response (31,32). To 
assess the breadth of this immune response, we compared these data to a previously published 
response of human decidua to a GBS infection (33). At 8 h pi, in contrast to GAS, GBS 
induced the expression of 32 genes of these pathways, including 9 of the 10 genes 
overexpressed after a GAS infection (Table S2). Most genes specifically activated during the 
GBS infection are related to “cellular response to cytokine stimulus”. Noteworthy, in contrast 
to GAS, genes overexpressed during GBS infection include subsets of secondary response 
genes, such as NFKB1, CCR7, CD80, and ICAM1 (32). This comparison indicates that GAS 
impairs the tissue robust immune response that can be elicited by a Streptococcus pathogen 
which elicits milder endometritis (34). Strikingly, among the tested genes the only one 
overexpressed by a GAS and not by a GBS infection is IL10, encoding an anti-inflammatory 
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cytokine. Altogether, these results show that GAS specifically induces a low and limited 
inflammation during the initiation of infection. 
To confirm the changes in gene expression, we quantified by qRT-PCR, on four 
additional tissues, the expression of five of the ten genes overexpressed after GAS infection at 
4 h and 8 h pi, in uninfected and infected tissues (Figure S2A, 4B). In addition, since IL6 is 
the classical pro-inflammatory cytokine and although its expression did not appear modified 
in the arrays, we quantified its expression in the same conditions (Figure S2A, 4B). 
Overexpression of two genes, CCL3 and CCL20 occurs as soon as 4 h pi; at 8 h pi the 
expression of TNF, CCL4, CXCL1, and CXCL2 is also increased (Figure 4B). Notably, qRT-
PCR assays confirm that IL6 is not significantly overexpressed after GAS infection, in 
contrast to the observed overexpression with GBS at 8 h pi (Table S2) (33). 
Because GAS is also able to modulate in vitro the accumulation of cytokines (35–37), we 
looked if the overexpression of six cytokine genes translated in an increase in protein 
concentrations in tissue supernatants (Figure S2B, 4C). The basal level of accumulation of the 
six cytokines in the control tissues 4 h and 8 h pi shows the same pattern, independently of the 
subject, with high concentrations of IL-6 and CXCL2 (Figure S2B, Table S3,S4), known to be 
highly expressed in different subsets of decidual cells during pregnancy (38). After infection, 
the accumulation of TNF, CCL3 and IL-1β is significantly increased as soon as 4 h pi and 
even more at 8 h pi (Figure 4C, Table S3, S4). Interestingly, the overexpression of the 
CXCL2 gene at 4 h and of the CXCL2 and CCL20 genes at 8 h (Figure 4B) are not paralleled 
by an increase in the concentrations of these two proteins (Figure 4C), suggesting that GAS 
also controls the immune response at a post-transcriptional level. 
GAS limiting the immune response at the transcriptional and post-transcriptional levels, 
we analyzed the potential roles of SLO and SpeB on that limitation. The activation of the 
tested genes was similar in the WT strain and the ΔSLO and ΔSpeB mutant strains (Figure 
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4B). In contrast, the SLO deficient strain generated a lower accumulation of TNF, CCL3, 
CXCL2 and IL-6, indicating that the presence of SLO increases these cytokines accumulation 
at 4 h pi (Figure 4C). Also, compared to the wild-type strain, the SpeB mutant had no effect 
on the accumulation of cytokines at 4 h pi, but induced a higher accumulation of TNF, CCL3, 
and CXCL2 at 8 h pi (Figure 4C). This indicates that SpeB tampers cytokine accumulation. 
Overall, GAS controls the immune response at the transcriptional and protein accumulation 
levels as soon as 4 h pi and SLO and SpeB are involved in the modulation of the immune 
response at the level of protein accumulation. 
Since GAS influences the cytokine accumulation, we wondered whether it also modified 
AMP accumulation, and whether SLO or SpeB intervened. Infecting tissues with the WT- 
strain did not change the amount of AMP present in the supernatant (Figure S3, Table S5, 
Table S6), indicating that GAS infection does not elicit AMP accumulation. Infecting with the 
ΔSpeB strain yielded the same result as with the WT strain (Figure S3). In contrast, infecting 
with the ΔSLO strain induced significantly less human defensins 1 and 2 accumulation at 4 h 
pi. This suggests that SLO leads, as for cytokine accumulation, to increased human defensin 1 
and 2 accumulation that is counterbalanced by other GAS-elicited signals.  
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Discussion 
GAS was, until the 20th century, the major cause of infectious maternal death (39) while not 
being a colonizer of the vaginal flora (11) and puerperal fever is still responsible for > 75 000 
maternal deaths per year, the most severe cases being caused by GAS (12). These data 
suggest that GAS has a particular propensity to elicit this disease. In addition, the onset of 
GAS puerperal fever occurs rapidly, the fever being established within two days following 
delivery. A comprehension of the crucial initial steps of GAS invasive infections and in 
particular puerperal fever is lacking. GAS possesses a large collection of virulence factors, 
but their role in the onset of these infections has not been characterized (7). Furthermore, the 
human specificity of GAS infections hinders the in vivo analysis of the initial steps. Using the 
original conjunction of ex vivo infection of human decidua, bacterial genetic manipulation, 
state-of-the-art image and immune response analyses, we demonstrated i) GAS adherence to 
and specific growth on the tissue within the first hours of infection, ii) GAS ability to invade 
the tissue by a proteolytic activity and maybe its persistence in immune cells and iii) GAS 
capacity to actively limit the host immune response (Figure 5). Our ex vivo setup, and 
particularly the live imaging, enabled us to dissect GAS capacity to establish decidua 
infection in real time and to approximate, with the presence of a flow, an in vivo situation. 
Our images demonstrate the presence of fibronectin and collagen at the surface of the 
decidua. It is unsurprising that GAS M28PF1 adheres to this tissue. Indeed, M28 strains, 
including M28PF1 (24), possess at least four fibronectin-binding proteins, Fba, SOF, SfbX 
and PrtF2, in addition to the six shared by strains from all genotypes. They also express one 
collagen-binding protein, Epf, in addition to the shared pilus and SpyAD (40). Finally, RD2, a 
32 kb DNA region quasi specific to emm28 strains modify, via encoded virulence factors and 
regulators, the virulence potential of emm28 strains, contributing to their association with 
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puerperal fever (41). The composition of the decidua surface and all these factors may explain 
the capacity of GAS to adhere to this tissue, a critical step in invasive puerperal fever. 
To our knowledge, our study provides the first estimate of GAS doubling time in contact 
with a human tissue. Roughly 80 minutes is in the range of doubling-times described for other 
pathogens in vivo (42,43) and given the rapidity with which puerperal fever occurs it probably 
reflects the growth during the initial colonization step. 
That GAS grows on the tissue of many subjects and in many uninfected conditioned 
supernatants, whereas it does not in the tissue culture medium, indicates that the decidua 
secretes nutrients and/or activation signals. In a controlled medium deprived of asparagine, 
SLO-induced endoplasmic reticulum stress leads to the secretion by epithelial cells of 
asparagine that promotes GAS growth (44). However, this mechanism required bacterial-cell 
contact and the medium we used for infection, RPMI, provides the 15 amino acids for which 
GAS is auxotroph (45). Since growth also occurred in uninfected conditioned supernatants, 
the secreted nutrient(s)/growth signal(s) are most likely not asparagine and defining them is 
the object of ongoing research. GAS grows on some tissues and conditioned supernatants and 
dies in others, suggesting that nutrient and/or bactericidal product secretion varies from 
subject to subject, both before and during infection. Whereas hBD1 and hBD2 concentrations 
were identical in all tissues, some differences may exist in that of LL-37. However, even if 
they existed, this would probably have little consequences on GAS killing since in vivo SpeB 
inactivates LL-37 at the bacterial surface representing a resistance mechanism (46). 
Interestingly, infection did not modify AMP concentration in the tissue supernatant, 
suggesting that the tissues display an intrinsic antimicrobial activity and that it may be 
controlled by GAS. 
During invasive infections, despite its absence of motility, GAS readily disseminates 
within tissue and eventually to blood vessels, demonstrating GAS capacity to invade tissues. 
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However, the crossing initiation, integrating the presence of extracellular matrix proteins has 
not, to our knowledge, been documented so far. Our data demonstrate that SpeB has an 
important role during the initial invasion step. Since SpeB has a broad proteolytic activity, 
including degrading extracellular matrix proteins, its role in tissue invasion is most likely 
linked to this capacity, degrading for instance the fibronectin which overlays the decidua (8). 
Yet, considering the pleiotropic effects of the absence of SpeB on the GAS surfactome and on 
GAS virulence mechanisms (8) our data cannot exclude that additional roles of SpeB are 
involved in the decreased invasion of the SpeB mutant strain. 
 Decidua parietalis is not covered by epithelial cells, the bacteria are therefore directly 
in contact, below the extracellular matrix proteins, with stromal and immune cells. Resident 
immune cells were followed by live imaging. Notably, neutrophils are normally scarce in the 
maternal-fetal membranes in the absence of infection (47). Phagocytic cells were present at 
the surface as soon as 15 min pi. Our data indicate that intra-tissular phagocytic cells readily 
capture surface bacteria in the first minutes of infection and that GAS is present at least 4 h pi 
in these cells. Although macrophages make an important contribution to the early control of 
GAS infection in intra-peritoneal murine model of infection (48), that GAS invades epithelial 
and immune cells and can survive or even escape from them has been documented in in vitro 
studies or during human biopsy analyses (49–51). Thus GAS ability to exploit the decidual 
inflammatory response by surviving inside phagocytic cells may be a virulence mechanism by 
favoring tissue persistence or/and invasion. 
GAS induces the cell death of half the cells in the decidua, stromal and immune cells. 
The DSLO mutant strain is less cytotoxic than the WT strain, supporting in vitro obtained 
conclusions (52) and the blebs we observe could be related to SLO-induced blebbing 
documented on different cell types (53,54). Also, the DSLO mutant strain is still able to 
induce decidual cell death, suggesting the cytotoxic action of other GAS secreted products, 
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such as the Streptolysin S (55). Hence, GAS cytotoxicity could account for phagocytic cells 
failure to cleanse the bacterial infection (56). 
Dense macrophage and neutrophil infiltrations are observed during severe invasive GAS 
soft tissue infections in humans (50). A limitation of ex vivo infections is the absence of 
recruitment of immune cells (56). However, our setup allowed the analysis of the tissue 
intrinsic capacity to secrete cytokine and chemokines and consequently to recruit circulating 
immune cells. The expression of cytokines that recruit neutrophils, CXCL1, CXCL2, CXCL3, 
and macrophages, CCL3, CCL4, respectively (32,57), was increased within 4 to 8 h pi. Yet, 
after an LPS injection neutrophils infiltrate decidua via an IL1-dependent mechanism (47). 
However, after GAS infection in our setup the IL-1β mRNA regulation varied from subject to 
subject. The slight increase in IL-1β observed at the protein level for some subjects may result 
from an inflammasome activation (58). A single-nucleotide polymorphism in the enhancer-
promoter region of IL1B gene has been associated with puerperal GAS sepsis susceptibility 
and could be responsible for the differences we observed (59).  
No change was detected for chemokines receptors, other cytokines, or signaling 
mediators, especially from NF-κB family, indicating the absence of the response 
amplification. Furthermore, IL-10, an anti-inflammatory cytokine, was induced in response to 
GAS infection. This constrained inflammation may favor GAS infection initiation by delaying 
or decreasing the recruitment of immune cells and account for the GAS – puerperal fever 
association. The SLO and SpeB pro- and anti-inflammatory roles, respectively, are in 
accordance with previous conclusions that indicated a proinflammatory role for SLO (60) and 
that the genuine role of several GAS effectors is to impair the immune system, favoring GAS 
colonization (61). Interestingly, whereas in vitro SLO and SpeB optimal productions are not 
simultaneous, being during the exponential and the stationary phase of growth, respectively 
(62), the modified responses observed with the mutant strains indicate that they are 
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sufficiently produced during the colonization and onset of invasion, as soon as 4 h pi, to fine-
tune the immune response and to limit AMP accumulation.  
Pathogens able to infect maternal-fetal interface are limited (63). Listeria monocytogenes 
causes foodborne disease with 12-20 times more prevalence in pregnant women, yet human 
decidua is a barrier to initial infection, inferring decidual stromal cells per se have defense 
mechanisms against L. monocytogenes (64). GBS is more prevalent in female reproductive 
tract than GAS but typically causes less severe maternal infection. In a model comparable to 
ours, where live GBS was in contact of decidua parietalis, GBS did not readily cross healthy 
term maternal-fetal membranes (65). GBS adherence to and penetration into the tissue was 
decreased at 8 h and 24 h pi compared to 4 h pi. In contrast to GAS, GBS, elicits robust 
increases of IL-6 and the chemokine CXCL8 (33). IL-6 has a pleiotropic effect on 
inflammation and CXCL-8 is one of the most important chemokine for the recruitment of 
neutrophils (57). Cell signaling molecules modulation was also noticeable only with GBS. 
Altogether, these data infer that GAS, in contrast to GBS, compromise the decidua innate 
response, including the upregulation of inflammatory mediators for neutrophil and 
macrophage recruitment. 
In several monitored phenotypes, namely tissue invasion, cytotoxicity and immune 
response restriction, the virulence factors SLO and SpeB intervened. Other virulence factors 
which have been implicated via in vitro studies in non-immune cell entry, phagocytosis, 
inflammation modulation could be tested by our holistic approach (8,16). Transposon libraries 
could also be tested with the aim of finding novel colonization or invasion factors specific to 
this or other tissues. Our approach can also be applied to the study of the initial steps of other 
pathogen infections on human decidua, to compare with GAS efficiency, or on other human 
tissues such as the skin. Finally, GAS actively multiplies, hides as intracellular bacteria and 
diverts the host response during the very first hours following decidua infection. This rapidity 
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may account both for the particular capacity of GAS, despite its quasi-absence from the 
female genital tract colonization, to elicit puerperal fevers and for their swift establishment. 
Our molecular decryption of GAS infection of the human decidua supports epidemiological 
conclusions for the necessity of maintaining and even increasing prophylactic measures (2,66) 
and the need to develop a vaccine to prevent life-threatening GAS infections such as 
puerperal fevers. 
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Methods 
Strains and culture conditions. The strains used in this study are described in Table S7. The 
M28PF1 strain is a clinical isolate responsible for an endometritis (French National Reference 
Center (CNR) for Streptococci, https://cnr-strep.fr/) that was selected on phenotypic and 
genotypic bases from a collection of 50 emm28 independent clinical isolates (24). GAS strains 
were grown under static condition at 37°C in Todd Hewitt broth supplemented with 0.2% 
Yeast Extract (THY) or on THY agar (THYA) plates. For GFP strains, the medium was 
supplemented with 10 µg/mL erythromycin.  
Genetic constructions and generation of GFP-producing and SLO- and SpeB-deleted 
mutant strains. The plasmids used in this study are described in table S7. The primers used for 
the generation of the plasmids and verifying the different strains are described in Table S8. 
The strains harboring an integrated inducible gfp gene were constructed as follows. We 
sequentially cloned into the pG1 vector (67), the Perm - gfp transcriptional fusion surrounded 
by the KpnI and HindIII sites from pATWgfp (68) giving rise to pG1-Perm-gfp. The lacA-
lacR intergenic sequence, enabling a single cross-over in M28PF1 and derivatives, was 
amplified using the primers F_lacA and R_lacA and cloned by In-fusion© into pG1-Perm-gfp 
digested with EcoRI, giving rise to pG1-lacA-Perm-gfp. The erm promoter was replaced by 
the tetO tetR Pxyl promoter region by amplifying it from pTCV_TetO (69) using the primers 
F_tetO and R_tetO and cloning it into pG1-lacA-Perm-gfp previously digested with EcoRI-
EcoRV, giving rise to pG1-lacA-PTetO-gfp. The plasmid was checked by sequencing and 
transferred into M28PF1 or derivatives by electroporation as previously described (70). The 
correct localization of the construct was confirmed by sequencing the region using a primer 
outside the construct (R_extlacA) and one hybridizing to the vector, RP48. The uninduced 
GFP-producing strains, grew like M28PF1 in laboratory THY. The construct was stable even 
in the absence of erythromycin for at least twelve generations. The anhydrotetracycline 
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(Sigma) concentration required for full expression of the GFP is 20-50 ng/mL and all bacteria 
are fluorescent after 90 minutes of induction, the fluorescence is stable for at least 6 h when 
the bacteria are in the stationary growth phase. GFP fluorescence is observable when GAS is 
intra-cellular. Induction of GFP does not affect strain growth. 
The ΔSLO and ΔSpeB strains correspond to in-frame deletion mutants of the slo and 
speB genes and were obtained by homologous recombination of the plasmid pG1-SLO and 
pG1-SpeB following the same protocol as previously (14,71). The DNA fragments 
encompassing speB and slo were cloned in BamHI – EcoRI digested pG1 using the In Fusion 
cloning kit® (Clonetech). This led to deletion of nucleotides 72 to 1155 and 76 to 1690 for 
speB and slo, respectively. The back-to-the-wild-type (BTSLO and BTSpeB) strain was 
obtained during the second cross-over which leads to the mutant or back to the wild-type 
strain. The regions surrounding the construct were sequenced.  
For all experiments, GAS strains were prepared as follows. Overnight cultures were 
diluted to an OD = 0.05 and grown in THY to the exponential phase (OD = 0.5), centrifuged 
and diluted in RPMI. For GFP expression, exponential phase bacteria were further diluted to 
an OD = 0.1 in THY supplemented with 10 µg/mL erythromycin and 20 ng/mL 
anhydrotetracyclin, grown for 1 h 30 min at 37°C and diluted in RPMI. 
Human tissue collection. Human placenta with attached maternal-fetal membranes 
were collected from healthy women with an uncomplicated singleton pregnancy, undergoing 
a planned cesarean delivery prior the onset of active labor at term (between 38 and 40 weeks 
of pregnancy). Except for per-operatively administered cephalosporin, women were excluded 
if prescription antibiotics were used during the two weeks preceding delivery. Table S1 
indicates in which experiments each sample tissue was used. 
Maternal-fetal membranes processing. Within 15 min of collection, biological 
samples were processed in the laboratory. Maternal-fetal membranes were detached from 
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placenta under sterile conditions, all similarly extensively rinsed in phosphate-buffered saline 
(PBS) and carefully examined. Pieces of membranes, at distance of placenta and of the 
remodeling zone overlying the cervix (13), free of surface blood clots, were cut and glued to 
Petri dishes or coverslips with a veterinary glue (Vetbond glue 3M, St Paul, MN), the fetal 
side sticking to the plastic or glass and covered with RPMI.  
In vitro bacterial growth measurement. RPMI was added to maternal-fetal tissues for 
8 h at 37°C, 5% CO2; the supernatants (conditioned supernatants) were subsequently filtered 
and diluted 1/5 with RPMI. A thousand bacteria/mL was added to these diluted supernatants 
or to RPMI alone. After 8 h of incubation at 37°C, 5% CO2, solutions were serially diluted 
and plated. After 24 h at 37°C, CFU were counted. 
Primary decidual stromal cells (DSC) culture, infection and analyses procedures. 
Cells from three subjects were isolated from decidua parietalis, obtained from maternal-fetal 
membranes of nonlaboring women after a normal term pregnancy and cultured as previously 
described (14). One mL of GAS in RPMI at a bacterial density corresponding to a MOI of 
100 was added to confluent DSCs for 4 h at 37°C, 5% CO2. Cells were extensively washed 
with PBS and fixed 15 min at 20°C with a 4% paraformaldehyde solution. Cytotoxicity was 
assessed using the cytotoxicity TUNEL staining following the manufacturer’s protocol 
(DeadEnd™ Fluorometric TUNEL System, Promega) and a LEICA DMI 6000 with a 20 µm 
objective (NA=0.5) for measurement. 
Antibodies. The following antibodies were used during this study: AlexaFluor 594 
mouse anti-CD45 (Biolegend, clone M5E2), rabbit anti-Fibronectin (Sigma, #F3648), rabbit 
anti-vimentin (Abcam, ab92547), mouse anti-Type IV collagen (DSHB, M3F7), rabbit anti-
whole GAS, gift from I. Julkunen. Secondary antibodies used were Alexafluor-594-coupled 
anti-rabbit and Alexafluor-647-coupled anti-mouse antibodies (Invitrogen).  
Experiments in static conditions (sc). 
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Immunofluorescence. 8 cm² or 1.5 cm² of maternal-fetal membranes were glued to a 
35 mm diameter Petri dish or on a 12 mm diameter glass coverslip respectively. When 
specified, tissues were pre-stained with anti-CD45 (1/100) for 30 min at 37°C, 5% CO2. 
Tissues were infected with 0.2 mL/cm² of a solution of 1.7 108 bacteria/mL in RPMI, 
supplemented by 10 µg/mL erythromycin and 50 ng/mL anhydrotetracycline (infection 
medium) when GFP strains were used. After infection, tissues were washed and fixed in 
formalin for 24 h, and then stored in 70% ethanol at 4°C until use. Fixed tissues were further 
cut into 0.5 cm² pieces and glued to coverslips, permeabilized with 0.2% triton X100 (Sigma) 
for 30 minutes at 20°C. Blocking solution (PBS+BSA 3%) was added for 1 h at 20°C, and 
tissues were stained for 4 h at 20°C with blocking solution containing primary antibodies: 
anti-GAS 1/250, anti-fibronectin 1/250, anti-type IV collagen 1/50, anti-Vimentin 1/250. 
Tissues were washed with PBS and secondary antibodies and DAPI (1/1000) in blocking 
solution were added for 1 hour at 20°C.  
Immuno-histo-fluorescence was performed on paraffin embedded tissues as described 
previously (18). 10 µm-thick slices were cut and stained with whole GAS rabbit antiserum 
(laboratory stock, 1/250) and with DAPI. 
TUNEL assay. 500 µl of RPMI were added to 1.5 cm² tissue glued to a 12 mm glass 
coverslip. A hundred µL of M28PF1 at 5.108 bacteria/mL was added directly to the tissue or 
in the upper chamber of a 6.5 mm Transwell® insert (polycarbonate, 0.4 µm membrane, 
Costar). For the non-infected condition, 100 µL of RPMI was added directly to the tissue. 
After the specified infection time, tissues were washed with PBS and fixed in formalin for 24 
h, and then stored in 70% ethanol at 4°C until use. 
Slight modifications were brought to the TUNEL manufacturer’s protocol. 0.5 cm² 
pieces of tissue were fixed and glued to coverslips and permeabilized with 500 µL PBS with 
0.2 % Triton X100 for 30 min at 20°C. A hundred µL of equilibration buffer (from the 
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manufacturer’s kit) was added on the tissues in a wet chamber for 15 min, liquid was removed 
and 50 µL of labelling solution was added for 3-4 h at 37°C. Tissues were washed twice with 
saline-sodium citrate 2X buffer (from the manufacturer’s kit) and stained with DAPI (1/2000) 
for 15 min. For double vimentin and TUNEL staining, TUNEL staining was performed first.  
Sc image acquisition. The maternal side of tissues was placed facing a 35 mm high 
glass bottom µ-dish (IBIDI) and imaged en face using a Yokogawa CSU-X1 Spinning Disk 
(Yokogawa, Tokyo, Japan) coupled with a DMI6000B Leica microscope (Leica microsystems 
Gmbh, Wetzlar, Germany). Acquisitions were made with MetaMorph 7 software. For 
quantification of bacterial invasion, images were acquired with a 40X objective (NA=1.25), 
0.3 µm z-step and approximatively 90 slices per stack were acquired. For cytotoxicity 
quantification, images were acquired with a 20X objective (NA=0.7), 1 µm z-step and for 
tissues approximatively 70 slices per stack were acquired. For measurements of bacterial 
thickness and surface coverage, 3 to 12 fields per tissue were analyzed.  
Sc image treatments and data analysis All images were processed with ImageJ. For 
cytotoxicity measurements, TUNEL and DAPI positive nuclei of images were segmented and 
automatically counted. At least 5 fields per condition were analyzed for tissues, and 10 fields 
for DSCs. To measure bacterial invasion, another ImageJ macro was used to segment 
bacterial particles on z-max projection image of GFP signal. For each bacterial particle, the 
axial localization was determined and compared to fibronectin and type IV collagen 
localization. Any bacterial particle whose signal was below 1.2 µm to fibronectin or collagen 
signals was considered as an invasion event. Five to 8 fields (153 x 169 x 30 µm) per 
conditions were analyzed. A GAS chain was considered to be on average 4 cocci, 
corresponding to the mean size of invading particles. We estimated the amount of invading 
chains by considering bacterial chains surface and thickness (mean thickness, 4 µm, bacterial 
coverage of a field: 90 %).  
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Bacterial layer thickness: 3D surface heat map was generated by a custom R code 
based on the plot-ly library. 
A 3D image representation of the tissue was performed using Imaris 7.4 (Bitplane 
AG). 
Experiments in flow conditions (fc): 8 cm² maternal-fetal explant were glued to a 35 
mm Petri dish and stained with Draq5 (1/2000) and anti-CD45 (1/100) in infection medium 
containing DAPI (1/30 000), fc infection medium, for 30 min at 37°C, 5% CO2. Tissues were 
extensively washed with fc infection medium and 3 mL of GFP-producing bacteria (1.108 
CFU/mL) in fc infection medium were added to the tissues in a 37°C microscopy chamber for 
45 minutes until 20-30 % of the tissue surface was covered by bacteria. Supernatant was then 
discarded, tissue washed with infection medium to remove unattached bacteria and a 
peristaltic pump with circulating infection medium bubbled with 95% O2 and 5% CO2 was 
activated in an open circuit at 0.3 mL/min.  
Fc image acquisition. Images of infected tissues were acquired en face with an upright 
DM6000FS Leica confocal microscope (Leica microsystems Gmbh, Wetzlar, Germany) 
coupled with a Yokogawa CSU-X1 Spinning Disk (Yokogawa, Tokyo, Japan), with a 25X 
objective (NA 0.95, Leica microsystems). Acquisitions were made with MetaMorph 7 
software and images were taken every 30 min for 3 h with a z-step of 2 µm. For long-term 
acquisition, axial drift was manually compensated after 3 h and acquisition was resumed for 
another 3 h. 
Fc image treatments and data analysis. All images were processed with ImageJ. 3D 
drifts of live images were corrected with custom routines. For surface area measurements of 
bacterial colonization, bacteria were segmented based on a threshold on the maximum 
intensity z projection images of the GFP signal at the different time points, with the same 
threshold for each time point. For local thickness measurement of the GFP signals 
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corresponding to bacteria, whole field was subdivided in region of interest and a custom 
ImageJ macro measured the full width at half maximum (FWHM) of the z-axis GFP signal. 
The thickness value obtained by measuring the FWHM was then converted in µm by 
measuring the mean FWHM of 20 single bacteria, considered to be 1 µm thick. 
Computer code availability. Computer codes used for this work will be transferred 
upon request. 
RNA extraction. Sc-obtained tissues were washed once and stored in TriReagents 
(Sigma) at -80°C until used. Total RNA was isolated using a Qiagen RNeasy Kit (Qiagen, 
Valencia, CA) according to the manufacturer's instructions. The purity and concentration of 
total RNA were evaluated using a Nanodrop spectrophotometer (Thermo Scientific, Waltham, 
MA), by measuring the ratio of absorbance at 260 nm and 280 nm. 
RT-qPCR analysis. RNAs were treated with deoxyribonuclease (Invitrogen, Life 
Technologies, St Aubin, France) to remove any contaminating DNA. Four µg of total RNA 
were reverse transcribed using random primers and M-MLV Reverse Transcriptase 
(Invitrogen), according to the manufacturer’s instructions. Quantitative PCR was carried out 
on a Light Cycler 480, 96 well apparatus (Roche Diagnostics, Manheim, Germany), with 160 
ng of cDNA as a template, using the amplification kit SensiFAST SYBR No-Rox kit (Bioline, 
London, UK), according to the manufacturer’s instructions. The RT2 Profiler “Inflammatory 
cytokines and receptors” and “Human innate and adaptive response” arrays PCR Arrays 
(Qiagen) were performed according to the manufacturer's instructions. Gene expression was 
normalized using a panel of 5 housekeeping genes: ACTB, B2M, GAPDH, HPRT1, RPLP0. 
ΔCt ranging from 0 and below to 6.0 were considered as maximum magnitude of gene 
expression, from 6.1 to 9.9 as moderate and from 10 to 15 as low. Primers for additional RT-
PCR analysis were chosen using PRIMER3 software, based on published sequences 
(available upon request). Primers were obtained from Eurogentec (Angers, France) and used 
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at 10 nM in the PCR reaction. In this series of experiment, the set of internal controls included 
the geometric mean of three different reference genes: SDHA, PPIA, and GAPDH. 
Genes with a nominal p value ≤ 0.05 were considered to be differentially expressed. 
Genes showing > 2-fold variation were further considered in the analysis. Heatmaps were 
created using the MeV Package. Enrichr was used for pathways enrichment analysis, 
restricted to Gene Ontology (GO) terms and ARCHS4 databases.  
GBS infection of maternal-fetal membranes microarray subanalysis. Data were 
extracted using GEO2R from Park et al. (33). After conversion of the Gene annotation using 
DAVID gene ID Conversion tool, fold-changes and p values for the 133 immune-related 
genes we previously analyzed with the RT²Profiler Arrays were retrieved from these 8 
samples. 
Protein and antimicrobial peptide analysis. Sc-obtained supernatants of explants were 
stored at − 80°C until use. The levels of IL6, TNF, CCL20, CXCL2, CCL3, and IL-1 b were 
measured with Bio-Plex® custom Assay (BIORAD) using a Bio-plex 200. AMP 
concentrations were analyzed in the same supernatants by ELISA with the following kits: 
LL37 (Hycult,biotech), human beta defensin 1 (R&D, Novus) and human beta defensin 2 
(Elabscience). The concentrations are reported as pg/mL medium. The samples were 
quantified in duplicate according to the manufacturers’ instructions. 
Statistics. Data were analyzed by Prism 6 software (GraphPad Software, Inc. San 
Diego, CA) or Xlstat version 2018.1 (Addinsoft, Paris, France). When indicated, we used 
Two-Way ANOVA. We used Student’s t-test or non-parametric tests for quantitative 
variables as indicated in the text and Pearson’s chi-square for qualitative variables, as 
appropriate. A p-value <0.05 was considered to be significant. 
Study approval. The study of the human maternal-fetal membranes was approved by 
the local ethics committee (Comité de Protection des Personnes Ile de France III, n°Am5724-
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1-COL2991, 05/02/2013). All participants provided written informed consent prior to 
inclusion in the study at the Department of Obstetrics, Port Royal Maternity, Cochin 
University Hospital, Paris, France.   
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Figure 1. GAS adheres to the decidua and grows on it using tissue secreted products. A, 
Imaris 3D representation of a tissue infected 16 h sc and imaged en face. Fibronectin, red; 
type IV collagen, yellow; GFP-GAS, green; DAPI, blue. Scale bar: 20 µm. Magnification: 
40X. B, Immuno-histofluorescence of a paraffin embedded tissue transversal slice (24 h pi, 
sc). Anti-GAS, green; DAPI, blue. Scale bar: 10 µm. Magnification: 100 X. C and E, z-max 
intensity projections of GFP signals from live fc en face acquisition images of GFP-WT at the 
tissue surface, at indicated time points, h:min. Scale bars: (C) 10 µm, (E) 20 µm. 
Magnification: 25 X. D, overtime ratio of the area covered by WT GAS GFP signal area in 
tissues C and from four other subjects compared to initial covered surface. Mean values of 3 
to 11 fields for each of the 5 tissues are plotted. Two-Way ANOVA to the first time point. F, 
Quantification of the surface covered by GFP GAS from image (E); red dotted line, 
exponential curve fitted starting at 105 min. R²=0.9948. G, 3D surface heat-map of the 
bacterial layer thickness at different time-points (live imaging, fc) h:min. x, y and z are 
scaled, color code in µm. Image size: 303 x 190 µm. H, Quantification of the bacterial layer 
mean thickness, mean values of 2 to 13 fields for each of the 5 tissues are plotted. Two-Way 
ANOVA to the first time point. I, Multiplication factor after GAS incubation for 8 h in tissue-
conditioned medium or RPMI. J, Basal levels of accumulation of the indicated antimicrobial 
peptide in the supernatant of non-infected decidual tissues 8 h after addition of fresh RPMI. 
Symbols same as in Figure 1I. For all panels, error bars are standard-error of the mean; 
values: ***, p<0.001, **, p<0.005.  
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Figure 2. Protease activity and persistence in decidual immune cells permit GAS tissue 
invasion. A, Orthogonal view of a tissue 16 h pi sc. Arrows indicate an invading particle. 
Fibronectin, red; type IV collagen, grey; GAS, green; DAPI, blue. Scale bar: 10 µm. 
Magnification: 40 X. B, Mean number of invading events per mm² at 4 h pi sc with the GFP-
WT strain calculated using high throughput image analysis. Four subjects are shown. C, Ratio 
of GFP-WT and GFP-ΔSpeB invading events 4 and 8 h pi sc. One-sample t-test to the WT at 
4 h for WT 8 h and ΔSpeB 4 h and to ΔSpeB 4 h for ΔSpeB 8 h. N=3. *, p<0.05. D, Time-
lapse (fc) of an immune cell phagocytosing GAS in situ, with orthogonal view. Anti-CD45 
(immune cell), grey; GAS, green; Draq5 (DNA), red. White arrows indicate the localization 
of the phagocytosis event. Scale bar: 10 µm. Magnification: 25 X. E, Orthogonal views of 
GFP-WT bacteria inside the tissue and within an immune cell; image taken 6 µm under the 
tissue surface 3 h pi fc. Anti-CD45, grey; bacteria, green; DAPI, blue. Scale bar: 5 µm. 
Magnification: 100 X.  
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Figure 3. GAS induces stromal and immune cells death via processes involving SLO and 
other secreted factors. A, Orthogonal view of a tissue 5 h pi sc prestained with anti-
fibronectin, red; anti-CD45 antibodies, yellow; WT-GFP bacteria, green; DAPI, grey. Scale 
bar: 10 µm, Magnification 40 X. B, Immunofluorescence of the decidua 16 h pi sc; DAPI, 
grey; TUNEL, green. Scale bar: 10 µm. Magnification: 63 X. C, Immunofluorescence of a 
tissue 16 h pi sc. Decidual stromal cells are vimentin+, CD45- and immune cells CD45+; 
Vimentin, red; DAPI, grey; CD45, yellow; TUNEL, green. Scale bar: 10 µm. Magnification: 
40 X. D, Immunofluorescence of tissue 4 h pi sc with the indicated strains; N.I., non-infected. 
DAPI, grey; TUNEL, green. Scale bar: 40 µm. Magnification: 20 X. E-G, Quantification of 
cytotoxicity by determination of the percentage of dead cells; E, on decidua with 3 subjects, 
in the absence, contact +, or the presence, contact -, of a Transwell® insert at indicated times; 
F, on primary decidual cells from three different subjects with indicated strains 4 h pi; N.I. 
non-infected; G, on decidua with 4 subjects with indicated strains, at indicated times. 
Statistical analysis E and G: Two-Way ANOVA with a Bonferroni post-test, *, p<0.05; **, 
p<0.005; ***, p<0.001; F: paired One-Way ANOVA, *, p<0.05. 
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Figure 4. Host cytokinic responses to GAS infection. A, Heat-map of the results from the 
qRT-PCR screening using RT²qPCR “Inflammatory cytokines and receptors” and “Human 
innate & adaptive response” arrays on 4 subjects, non-infected (NInf) or infected 8 h sc with 
the WT strain (Inf). Cytokines significantly overexpressed in the infected compared to non-
infected condition are shown in red. B and C, Fold-change variation of B, the expression of 
the immune-related genes after infection with the indicated WT or mutant strains for left, 4 h 
and right, 8 h pi compared to the non-infected expression. Statistical analysis: Mann-Whitney 
U test, one-way; a, p<0.05 as compared to non-infected. C, the concentration of the indicated 
cytokines compared to the non-infected condition at left, 4 h and right, 8 h pi on tissues from 
4 different subjects. Statistical analysis: Friedman and post hoc pairwise comparison tests, a 
as in B b, p<0.05 as compared to WT. B and C, Axes are in log2. Symbols as in Figure 1I. 
Means are indicated with black lines. Dotted lines correspond to the value of 1.  
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Figure 5. Figure 5. Schematic representation of the initial steps of decidua invasive 
infection by GAS. The successive steps are represented. 1) Decidua secretes anti-microbial 
peptides and nutrients (Figure 1I and S3) promoting GAS multiplication at the tissue surface 
(Figure 1C-H). 2) GAS invades the tissue in an SpeB-dependent manner, most likely through 
its capacity to degrade fibronectin (Figure 2A, B, C). 3) GAS is phagocytosed at the surface 
and is present inside decidual immune cells at least 6 µm below the surface and 4 h pi, 
suggesting GAS may use immune decidual cells to invade the decidua (Figure 2 D-E). 4) 
GAS induces the death of decidual stromal and immune cells in an SLO-dependent 
mechanism (Figure 3). 5) GAS limits the innate immune response, impairing the response 
amplification (Figure 4). Decidual immune and stromal cells are represented as observed in 
the tissue; bent arrows, nutriments, AMP, or growth signaling factors secretion and diffusion; 
dotted line objects, damaged cells; dotted arrows, cytokine secretion; red line, accumulation 
repression; green arrow, accumulation induction. 
 
